keyword
https://read.qxmd.com/read/38669521/peripheral-blood-biomarkers-associated-with-combination-of-immune-checkpoint-blockade-plus-chemotherapy-in-nsclc
#1
JOURNAL ARTICLE
Nozomu Kimura, Yoko Tsukita, Risa Ebina-Shibuya, Eisaku Miyauchi, Mitsuhiro Yamada, Daisuke Narita, Ryota Saito, Chihiro Inoue, Naoya Fujino, Tomohiro Ichikawa, Tsutomu Tamada, Hisatoshi Sugiura
BACKGROUND: Biomarkers predicting clinical outcomes of treating non-small cell lung cancer (NSCLC) with combination of immune checkpoint inhibitors (ICIs) and chemotherapy would be valuable. OBJECTIVE: This study aims to seek predictors of combination of ICI/chemotherapy response in NSCLC patients using peripheral blood samples. METHODS: Patients diagnosed with advanced NSCLC between July 2019 and May 2021 receiving combination of ICI/chemotherapy were included and assessed for partial responses (PR), stable disease (SD) or progressive disease (PD)...
March 20, 2024: Cancer Biomarkers: Section A of Disease Markers
https://read.qxmd.com/read/38669141/precision-off-the-shelf-natural-killer-cell-therapies-for-oncology-with-logic-gated-gene-circuits
#2
JOURNAL ARTICLE
Nicholas W Frankel, Han Deng, Gozde Yucel, Marcus Gainer, Nelia Leemans, Alice Lam, Yongshuai Li, Michelle Hung, Derrick Lee, Chen-Ting Lee, Andrew Banicki, Mengxi Tian, Niran Almudhfar, Lawrence Naitmazi, Assen Roguev, Seunghee Lee, Wilson Wong, Russell Gordley, Timothy K Lu, Brian S Garrison
Acute myeloid leukemia (AML) is an aggressive disease with a poor prognosis (5-year survival rate of 30.5% in the United States). Designing cell therapies to target AML is challenging because no single tumor-associated antigen (TAA) is highly expressed on all cancer subpopulations. Furthermore, TAAs are also expressed on healthy cells, leading to toxicity risk. To address these targeting challenges, we engineer natural killer (NK) cells with a multi-input gene circuit consisting of chimeric antigen receptors (CARs) controlled by OR and NOT logic gates...
April 25, 2024: Cell Reports
https://read.qxmd.com/read/38669099/establishment-and-assessment-of-mortality-risk-prediction-model-in-patients-with-sepsis-based-on-early-stage-peripheral-lymphocyte-subsets
#3
JOURNAL ARTICLE
Fuzhu Li, Hongtao Qu, Yimin Li, Jie Liu, Hongyun Fu
This study is aimed to explore the value of lymphocyte subsets in evaluating the severity and prognosis of sepsis. The counts of lymphocytes, CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ B cells, and NK cells significantly decreased between day 1 and day 3 in both the survivor and the non-survivor groups. The peripheral lymphocyte subsets (PLS) at day 1 were not significantly different between the survivor and the non-survivor groups. However, at day 3, the counts of lymphocytes, CD3+ T cells, CD4+ T cells, and NK cells were remarkably lower in the non-survivor group...
April 25, 2024: Aging
https://read.qxmd.com/read/38669064/spatial-profiling-of-ovarian-carcinoma-and-tumor-microenvironment-evolution-under-neoadjuvant-chemotherapy
#4
JOURNAL ARTICLE
Elisa Yaniz-Galende, Qinghe Zeng, Juan Francisco Grau-Bejar, Christophe Klein, Félix Blanc-Durand, Audrey Le Formal, Eric Pujade-Lauraine, Laure Chardin, Elodie Edmond, Virginie Marty, Isabelle Ray-Coquard, Florence Joly, Gwenaël Ferron, Patricia Pautier, Dominique Berton-Rigaud, Alain Lortholary, Nadine Dohollou, Christophe Desauw, Michel Fabbro, Emmanuelle Malaurie, Nathalie Bonichon-Lamichhane, Diana Bello Roufai, Justine Gantzer, Etienne Rouleau, Catherine Genestie, Alexandra Leary
PURPOSE: Immune tumor microenvironment (iTME) determines ovarian cancer development. This study investigates changes in HLA-I expression, CD8+/Foxp3 ratio, CD8+ cells and coregulators density at diagnosis and upon neoadjuvant chemotherapy (NACT), correlating changes with clinical outcomes. EXPERIMENTAL DESIGN: Multiplexed immune profiling and cell clustering analysis was performed on paired matched OC samples to characterize the iTME at diagnosis and under NACT from patients enrolled in the CHIVA trial (NCT01583322)...
April 26, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38668728/generation-of-an-inhibitory-nk-cell-subset-by-tgf-%C3%AE-1-il-15-polarization
#5
JOURNAL ARTICLE
Douglas C Chung, Carlos R Garcia-Batres, Douglas G Millar, Stephanie W Y Wong, Alisha R Elford, Jessica A Mathews, Ben X Wang, Linh T Nguyen, Patricia A Shaw, Blaise A Clarke, Marcus Q Bernardini, Adrian G Sacher, Sarah Q Crome, Pamela S Ohashi
NK cells have been shown to exhibit inflammatory and immunoregulatory functions in a variety of healthy and diseased settings. In the context of chronic viral infection and cancer, distinct NK cell populations that inhibit adaptive immune responses have been observed. To understand how these cells arise and further characterize their immunosuppressive role, we examined in vitro conditions that could polarize human NK cells into an inhibitory subset. TGF-β1 has been shown to induce regulatory T cells in vitro and in vivo; we therefore investigated if TGF-β1 could also induce immunosuppressive NK-like cells...
April 26, 2024: Journal of Immunology
https://read.qxmd.com/read/38668247/complete-rescue-of-htlv-1-p12ko-infectivity-by-depletion-of-monocytes-together-with-nk-and-cd8-t-cells
#6
JOURNAL ARTICLE
Anna Gutowska, Sarkis Sarkis, Mohammad Arif Rahman, Katherine C Goldfarbmuren, Ramona Moles, Massimiliano Bissa, Melvin Doster, Robyn Washington-Parks, Katherine McKinnon, Isabela Silva de Castro, Luca Schifanella, Genoveffa Franchini, Cynthia A Pise-Masison
The transient depletion of monocytes alone prior to exposure of macaques to HTLV-1 enhances both HTLV-1WT (wild type) and HTLV-1p12KO (Orf-1 knockout) infectivity, but seroconversion to either virus is not sustained over time, suggesting a progressive decrease in virus expression. These results raise the hypotheses that either HTLV-1 persistence depends on a monocyte reservoir or monocyte depletion provides a transient immune evasion benefit. To test these hypotheses, we simultaneously depleted NK cells, CD8+ T cells, and monocytes (triple depletion) prior to exposure to HTLV-1WT or HTLV-1p12KO ...
March 29, 2024: Pathogens
https://read.qxmd.com/read/38667297/tumor-microenvironment-modulation-by-cancer-derived-extracellular-vesicles
#7
REVIEW
Artem Ten, Vadim Kumeiko, Vladislav Farniev, Huile Gao, Maxim Shevtsov
The tumor microenvironment (TME) plays an important role in the process of tumorigenesis, regulating the growth, metabolism, proliferation, and invasion of cancer cells, as well as contributing to tumor resistance to the conventional chemoradiotherapies. Several types of cells with relatively stable phenotypes have been identified within the TME, including cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), neutrophils, and natural killer (NK) cells, which have been shown to modulate cancer cell proliferation, metastasis, and interaction with the immune system, thus promoting tumor heterogeneity...
April 15, 2024: Cells
https://read.qxmd.com/read/38667291/the-smoothened-agonist-sag-modulates-the-male-and-female-peripheral-immune-systems-differently-in-an-immune-model-of-central-nervous-system-demyelination
#8
JOURNAL ARTICLE
Abdelmoumen Kassoussi, Amina Zahaf, Tom Hutteau-Hamel, Claudia Mattern, Michael Schumacher, Pierre Bobé, Elisabeth Traiffort
Both Hedgehog and androgen signaling pathways are known to promote myelin regeneration in the central nervous system. Remarkably, the combined administration of agonists of each pathway revealed their functional cooperation towards higher regeneration in demyelination models in males. Since multiple sclerosis, the most common demyelinating disease, predominates in women, and androgen effects were reported to diverge according to sex, it seemed essential to assess the existence of such cooperation in females...
April 13, 2024: Cells
https://read.qxmd.com/read/38666913/augmenting-the-antitumor-efficacy-of-natural-killer-cells-via-synnotch-receptor-engineering-for-targeted-il-12-secretion
#9
JOURNAL ARTICLE
Ali Ahmadnia, Saeed Mohammadi, Ahad Yamchi, Mohamad Reza Kalani, Touraj Farazmandfar, Ayyoub Khosravi, Ali Memarian
Natural killer (NK) cells are crucial components of innate immunity, known for their potent tumor surveillance abilities. Chimeric antigen receptors (CARs) have shown promise in cancer targeting, but optimizing CAR designs for NK cell functionality remains challenging. CAR-NK cells have gained attention for their potential to reduce side effects and enable scalable production in cancer immunotherapy. This study aimed to enhance NK cell anti-tumor activity by incorporating PD1-synthetic Notch (synNotch) receptors...
March 28, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38666906/genetic-variant-of-dnam-1-rs763361-c-t-is-associated-with-ankylosing-spondylitis-in-a-mexican-population
#10
JOURNAL ARTICLE
Alejandro Vázquez-Reyes, José Francisco Zambrano-Zaragoza, Juan Manuel Agraz-Cibrián, Miriam Fabiola Ayón-Pérez, Gloria Yareli Gutiérrez-Silerio, Susana Del Toro-Arreola, Alan Guillermo Alejandre-González, Liliana Ortiz-Martínez, Jesse Haramati, Iris Celeste Tovar-Ocampo, Marcelo Victorio-De Los Santos, Jorge Gutiérrez-Franco
DNAM-1 (CD226) is an activating receptor expressed in CD8+ T cells, NK cells, and monocytes. It has been reported that two SNPs in the DNAM-1 gene, rs763361 C>T and rs727088 G>A, have been associated with different autoimmune diseases; however, the role of DNAM-1 in ankylosing spondylitis has been less studied. For this reason, we focused on the study of these two SNPs in association with ankylosing spondylitis. For this, 34 patients and 70 controls were analyzed using endpoint PCR with allele-specific primers...
March 23, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38666504/cd155-tigit-axis-as-a-therapeutic-target-for-cancer-immunotherapy
#11
REVIEW
Yeteng Mu, Xingang Guan
Immune checkpoint inhibitors (ICIs) have shown unprecedented efficacy in treating many advanced cancers. Although FDA-approved ICIs have shown promising efficacy in treating many advanced cancers, their application is greatly limited by the low response rate, immune-related adverse events (irAE), and drug resistance. Developing novel ICIs holds great promise to improve the survival and prognosis of advanced cancer patients. T-Cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on T cells, natural killer (NK) cells, and T regulatory cells...
2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38665020/analgesic-mechanism-of-dexmedetomidine-and-esketamine-in-rats-with-spinal-cord-injury
#12
JOURNAL ARTICLE
Huiting Zhao, Zhuocheng Li
BACKGROUND: Spinal cord injury (SCI) is usually caused by external direct or indirect factors, and with a high morbidity and mortality rate. The aim of this study was to observe the effects of Dexmedetomidine (DEX) combined with Esketamine (ESK) on pain behavior and potential analgesic mechanisms in rats with SCI. The goal was to provide a reliable multimodal analgesic medication regimen for SCI. METHODS: Thirty rats were divided into five groups with six rats in each group: Sham group, SCI group, DEX group, ESK group, and DEX+ESK group...
April 2024: Discovery Medicine
https://read.qxmd.com/read/38664735/slc27a2-is-a-potential-immune-biomarker-for-hematological-tumors-and-significantly-regulates-the-cell-cycle-progression-of-diffuse-large-b-cell-lymphoma
#13
JOURNAL ARTICLE
Yi Wang, Xue Chen, Yun Li, Zhixue Zhang, Leiming Xia, Jiang Jiang, Yuqin Chai, Ziming Wang, Yu Wan, Tongyu Li, Fengbo Jin, Hongxia Li
BACKGROUND: Research on the fatty acid metabolism related gene SLC27A2 is currently mainly focused on solid tumors, and its mechanism of action in hematological tumors has not been reported. METHOD: This study aims to explore the pathological and immune mechanisms of the fatty acid metabolism related gene SLC27A2 in hematological tumors and verify its functional role in hematological tumors through cell experiments to improve treatment decisions and clinical outcomes of hematological tumors...
April 25, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38663106/helminth-derived-molecules-improve-5-fluorouracil-treatment-on-experimental-colon-tumorigenesis
#14
JOURNAL ARTICLE
Mónica G Mendoza-Rodríguez, Daniela Medina-Reyes, Cuauhtémoc A Sánchez-Barrera, Karen V Fernández-Muñoz, Verónica García-Castillo, Jorge L Ledesma-Torres, Marisol I González-González, José L Reyes, Carlos Pérez-Plascencia, Miriam Rodríguez-Sosa, Felipe Vaca-Paniagua, Marco A Meraz, Luis I Terrazas
Colorectal cancer (CRC) is one of the most prevalent fatal neoplasias worldwide. Despite efforts to improve the early diagnosis of CRC, the mortality rate of patients is still nearly 50%. The primary treatment strategy for CRC is surgery, which may be accompanied by chemotherapy and radiotherapy. The conventional and first-line chemotherapeutic agent utilized is 5-fluorouracil (5FU). However, it has low efficiency. Combination treatment with leucovorin and oxaliplatin or irinotecan improves the effectiveness of 5FU therapy...
April 24, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38663041/comprehensive-analysis-of-the-immune-implication-of-ephx4-gene-in-laryngeal-squamous-cell-carcinoma
#15
JOURNAL ARTICLE
Nimei Shen, Gang Gao, Xinhong Lu, Jiaxin Jin, Liwei Lin, Maohua Qian, Yang Qin
OBJECTIVES: The role of Epoxide Hydrolase-4 (EPHX4), a member of epoxide hydrolase family, has not been investigated in cancer. The purpose of this article is to explore the application value of EPHX4 in laryngeal cancer and its relationship with immune infiltration. METHODS: We observed that EPHX4 expression and its survival assays in laryngeal cancer specimens based on The Cancer Genome Atlas (TCGA) cohorts. We also analyzed the correlation between immune cell infiltration levels and EPHX4 gene copy number in laryngeal cancer...
March 7, 2024: Brazilian Journal of Otorhinolaryngology
https://read.qxmd.com/read/38662990/ocrelizumab-alters-cytotoxic-lymphocyte-function-while-reducing-ebv-specific-cd8-t-cell-proliferation-in-patients-with-multiple-sclerosis
#16
JOURNAL ARTICLE
Gianmarco Abbadessa, Maria Teresa Lepore, Sara Bruzzaniti, Erica Piemonte, Giuseppina Miele, Elisabetta Signoriello, Francesco Perna, Chiara De Falco, G Lus, Giuseppe Matarese, Simona Bonavita, Mario Galgani
BACKGROUND AND OBJECTIVES: The role of B cells in the pathogenic events leading to relapsing multiple sclerosis (R-MS) has only been recently elucidated. A pivotal step in defining this role has been provided by therapeutic efficacy of anti-CD20 monoclonal antibodies. Indeed, treatment with anti-CD20 can also alter number and function of other immune cells not directly expressing CD20 on their cell surface, whose activities can contribute to unknown aspects influencing therapeutic efficacy...
July 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38662170/peripheral-nk-cells-identified-as-the-predictor-of-response-in-extensive-stage-small-cell-lung-cancer-patients-treated-with-first-line-immunotherapy-plus-chemotherapy
#17
JOURNAL ARTICLE
Yanan Cui, Yanping Chen, Peiyan Zhao, Shuang Li, Ying Cheng, Xiubao Ren
PURPOSE: Although immunotherapy improves outcomes in extensive-stage small-cell lung cancer (ES-SCLC), the search for biomarkers predicting treatment success is crucial. Natural killer (NK) cells are potential indicators in various cancers, however, their precise role in ES-SCLC prognosis remains unclear. METHODS: In this retrospective study, 33 patients with ES-SCLC treated with first-line immuno-chemotherapy were enrolled. The peripheral NK cell percentage and its longitudinal dynamics were analyzed using flow cytometry...
April 25, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38662155/galectin-9-a-pro-survival-factor-inducing-immunosuppression-leukemic-cell-transformation-and-expansion
#18
REVIEW
Cansu Yıldırım
Leukemia is a malignancy of the bone marrow and blood originating from self-renewing cancerous immature blast cells or transformed leukocytes. Despite improvements in treatments, leukemia remains still a serious disease with poor prognosis because of disease heterogeneity, drug resistance and relapse. There is emerging evidence that differentially expression of co-signaling molecules play a critical role in tumor immune evasion. Galectin-9 (Gal-9) is one of the key proteins that leukemic cells express, secrete, and use to proliferate, self-renew, and survive...
April 25, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38661718/dual-fluorescence-reporter-mice-for-ccl3-transcription-translation-and-intercellular-communication
#19
JOURNAL ARTICLE
Maria Belen Rodrigo, Anna De Min, Selina Kathleen Jorch, Cristina Martin-Higueras, Ann-Kathrin Baumgart, Beata Goldyn, Sara Becker, Natalio Garbi, Niels A Lemmermann, Christian Kurts
Chemokines guide immune cells during their response against pathogens and tumors. Various techniques exist to determine chemokine production, but none to identify cells that directly sense chemokines in vivo. We have generated CCL3-EASER (ErAse, SEnd, Receive) mice that simultaneously report for Ccl3 transcription and translation, allow identifying Ccl3-sensing cells, and permit inducible deletion of Ccl3-producing cells. We infected these mice with murine cytomegalovirus (mCMV), where Ccl3 and NK cells are critical defense mediators...
July 1, 2024: Journal of Experimental Medicine
https://read.qxmd.com/read/38661717/regulation-of-pulmonary-plasma-cell-responses-during-secondary-infection-with-influenza-virus
#20
JOURNAL ARTICLE
Andrew J MacLean, Joao P P L Bonifacio, Sophia L Oram, Mona O Mohsen, Martin F Bachmann, Tal I Arnon
During secondary infection with influenza virus, plasma cells (PCs) develop within the lung, providing a local source of antibodies. However, the site and mechanisms that regulate this process are poorly defined. Here, we show that while circulating memory B cells entered the lung during rechallenge and were activated within inducible bronchus-associated lymphoid tissues (iBALTs), resident memory B (BRM) cells responded earlier, and their activation occurred in a different niche: directly near infected alveoli...
July 1, 2024: Journal of Experimental Medicine
keyword
keyword
1651
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.